Legal & General Group Plc purchased a new position in National Vision Holdings, Inc. (NASDAQ:EYE – Free Report) in the 2nd quarter, HoldingsChannel reports. The institutional investor purchased 182,968 shares of the company’s stock, valued at approximately $3,478,000.
Other institutional investors and hedge funds have also made changes to their positions in the company. The Manufacturers Life Insurance Company purchased a new stake in shares of National Vision in the second quarter worth about $669,000. Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of National Vision during the 2nd quarter worth approximately $2,817,000. William Blair Investment Management LLC purchased a new position in National Vision during the second quarter valued at $90,248,000. NFJ Investment Group LLC purchased a new position in National Vision in the 2nd quarter valued at $2,069,000. Finally, Meeder Asset Management Inc. purchased a new position in shares of National Vision during the 2nd quarter worth $101,000.
Wall Street Analysts Forecast Growth
EYE has been the topic of a number of recent research reports. Bank of America cut their price target on shares of National Vision from $35.00 to $30.00 and set a “buy” rating on the stock in a research note on Thursday, May 14th. UBS Group cut their target price on National Vision from $36.00 to $34.00 and set a “buy” rating for the company in a research note on Thursday, August 13th. Barclays reduced their price target on shares of National Vision from $38.00 to $27.00 and set an “overweight” rating on the stock in a report on Thursday, May 14th. Morgan Stanley reduced their target price on National Vision from $22.00 to $21.00 and set an “equal weight” rating on the stock in a research report on Thursday, August 13th. Finally, Roth Capital reiterated a “buy” rating and issued a $27.00 target price on shares of National Vision in a report on Thursday, August 13th. Seven investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat.com, National Vision currently has a consensus rating of “Moderate Buy” and an average price target of $30.36.
National Vision Price Performance
NASDAQ EYE opened at $16.74 on Friday. The company has a market cap of $1.32 billion, a PE ratio of 27.44, a PEG ratio of 1.33 and a beta of 0.98. National Vision Holdings, Inc. has a 1 year low of $14.75 and a 1 year high of $30.02. The company has a current ratio of 0.59, a quick ratio of 0.27 and a debt-to-equity ratio of 0.25. The stock’s 50-day moving average price is $19.76 and its two-hundred day moving average price is $21.63.
National Vision (NASDAQ:EYE – Get Free Report) last posted its quarterly earnings results on Wednesday, August 12th. The company reported $0.25 earnings per share for the quarter, topping analysts’ consensus estimates of $0.18 by $0.07. The company had revenue of $498.81 million during the quarter. National Vision had a return on equity of 6.78% and a net margin of 2.47%.The firm’s revenue for the quarter was up 2.6% on a year-over-year basis. During the same period last year, the business earned $0.18 earnings per share. On average, analysts predict that National Vision Holdings, Inc. will post 0.65 EPS for the current year.
National Vision Profile
National Vision Holdings, Inc is an American optical retailer specializing in accessible vision care and eyewear. The company operates under multiple retail banners, offering comprehensive eye health services and a wide range of optical products. Since its founding in the early 1990s, National Vision has focused on providing value-driven solutions, targeting underserved and price?conscious consumer segments.
Through its primary retail brands—including America’s Best Contacts & Eyeglasses, Eyeglass World, Optical America and Vista Optical—National Vision delivers services such as comprehensive eye examinations, prescription eyewear, contact lenses, sunglasses and lens accessories.
Read More
- Five stocks we like better than National Vision
- Revolution Medicines Got Its Breakthrough—What Moves It Next?
- Retail Earnings Just Exposed a Bigger Divide in the U.S. Consumer Economy
- FB Financial’s Southern Expansion and Buybacks Drive Analyst Optimism
- AST SpaceMobile Stock Soared 12%—This Was the Catalyst
Want to see what other hedge funds are holding EYE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Vision Holdings, Inc. (NASDAQ:EYE – Free Report).
Receive News & Ratings for National Vision Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Vision and related companies with MarketBeat.com's FREE daily email newsletter.
